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Abstract
Background: The outermost layer of the bacterial surface is of crucial importance because it is in
constant interaction with the host. Glycopeptidolipids (GPLs) are major surface glycolipids present
on various mycobacterial species. In the fast-grower model organism Mycobacterium smegmatis,
GPL biosynthesis involves approximately 30 genes all mapping to a single region of 65 kb.
Results: We have recently sequenced the complete genomes of two fast-growers causing human
infections, Mycobacterium abscessus (CIP 104536T) and M. chelonae (CIP 104535T). We show here
that these two species contain genes corresponding to all those of the M. smegmatis "GPL locus",
with extensive conservation of the predicted protein sequences consistent with the production of
GPL molecules indistinguishable by biochemical analysis. However, the GPL locus appears to be
split into several parts in M. chelonae and M. abscessus. One large cluster (19 genes) comprises all
genes involved in the synthesis of the tripeptide-aminoalcohol moiety, the glycosylation of the
lipopeptide and methylation/acetylation modifications. We provide evidence that a duplicated
acetyltransferase (atf1 and atf2) in M. abscessus and M. chelonae has evolved through specialization,
being able to transfer one acetyl at once in a sequential manner. There is a second smaller and
distant (M. chelonae, 900 kb; M. abscessus, 3 Mb) cluster of six genes involved in the synthesis of the
fatty acyl moiety and its attachment to the tripeptide-aminoalcohol moiety. The other genes are
scattered throughout the genome, including two genes encoding putative regulatory proteins.
Conclusion: Although these three species produce identical GPL molecules, the organization of
GPL genes differ between them, thus constituting species-specific signatures. An hypothesis is that
the compact organization of the GPL locus in M. smegmatis represents the ancestral form and that
evolution has scattered various pieces throughout the genome in M. abscessus and M. chelonae.
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Background
Mycobacterium abscessus and M. chelonae are both species
of rapidly growing mycobacteria (RGM) that have
emerged as significant pathogens in humans during the
last ten years: both species are major causes of skin and
soft tissue infections following medical or surgical proce-
dures [1]; M. abscessus also causes pulmonary infections
and is increasingly recovered from patients with cystic
fibrosis [1]. M. chelonae and M. abscessus are among the
most-antibiotic resistant RGM species [1] and this has
serious consequences for therapy [2].
Glycopeptidolipids (GPLs) are surface lipids found on a
number of mycobacterial species including both RGM
(e.g., M. smegmatis, M. chelonae, M. abscessus) and slow
growing mycobacteria (e.g., M. avium subsp.  avium).
These molecules can make up more than 70% of the lipids
exposed at the bacterial surface (for a review see [3-5]).
They have a glycosylated lipopeptide core that is variably
modified by O-methylation and O-acetylation (Fig. 1).
More precisely, the GPL structure is based on a tripeptide-
aminoalcohol (D-Phe-D-allo-Thr-D-Ala-L-alaninol)  N-
linked to a long chain fatty acyl residue. This lipopeptide
core is substituted by a 6-deoxytalosyl (dTal) unit linked
to the allo-Thr residue and by an O-methylated rhamnosyl
unit linked to the terminal alaninol residue. The dTal res-
idue can be O-acetylated on positions 3 and 4, further gly-
cosylated on position 2 in M. avium, whereas the fatty acyl
moiety and the rhamnosyl residue can be modified with
one and three methyl groups on positions 2, 3, or 4,
respectively and in some cases further glycosylated by the
addition of an extra rhamnosyl unit [3,11,6] (Fig. 1).
GPLs are required for sliding motility, biofilm formation
and for maintaining cell wall integrity [7,8]. They also
influence bacterial aggregation [7,9], induce the release of
prostaglandin E2 and interfere with the interaction
between mycobacteria and human monocytes/macro-
phages [10,11]. Moreover, several recent studies show that
natural variants of M. abscessus, which produce only small
amounts of GPL are more invasive than the high-level
producers [12-14]. Thus, GPLs appear to play an impor-
tant role in both the physiology and the pathogenicity of
mycobacteria.
The complete genomes of M. chelonae (CIP 104535T) and
M. abscessus (CIP 104536T) have recently been sequenced
to help to elucidate their molecular mechanisms of path-
ogenicity and antibiotic resistance. By exploiting available
data concerning the genetic basis of the GPL biosynthetic
pathway in the RGM model organism, M. smegmatis, we
identified and analysed the genetic regions encoding
enzymes involved in GPL biosynthesis in M. chelonae and
M. abscessus.
Results
Biochemical analysis of the glycopeptidolipid produced by 
M. abscessus and M. chelonae
Since GPL molecules may differ at a structural level, we
first assessed the GPL status of the strains used in this
study for comparative genomic analysis: M. smegmatis
mc2155, M. chelonae CIP 104535T and M. abscessus CIP
104536T. Strains were grown in both early exponential
and late stationary phases (Fig. 2A) and lipids were
extracted from cells [11]. The GPLs were identified by
thin-layer chromatography (TLC), a method separating
molecules according to their hydrophobic index, and
using matrix-assisted laser desorption/ionization time of
flight (MALDI-TOF) mass spectrometry analysis [11].
Since GPLs contain sugar moieties, GPL-like compounds
were identified by anthrone staining [7]. Whatever the
growth phase, the three strains produced similar diglyco-
sylated GPLs, and in comparable quantities; however, trig-
lycosylated GPLs were clearly more abundant in M.
chelonae and M. abscessus than in M. smegmatis in both
conditions (Fig. 2A). The precise nature of the GPL-like
compounds was resolved by MALDI-TOF mass spectrom-
etry, a very accurate and sensitive method for detecting
glycolipids. The molecular masses of all the GPL-associ-
ated pseudomolecular ions peaks detected in the mass
spectra of all strains perfectly matched the previously cal-
culated molecular weights of the GPLs in these strains.
Most of the GPLs produced by M. smegmatis mc2155 were
diglycosylated forms, confirming earlier reports [15]. M.
abscessus  and  M. chelonae produced the same diglyco-
sylated GPLs ([M+K+] m/z at 1273 amu), and in addition
produced a higher amount of triglycosylated GPLs than
M. smegmatis ([M+K+] m/z at 1419 amu) as expected from
TLC analysis (Fig. 2B).
Comparative genomics of the GPL biosynthetic pathway
Comparative genomic analysis was performed by pairwise
alignments of the proteins of the GPL locus of M. smegma-
tis and each of the complete proteomes of M. abscessus and
M. chelonae [16,17]. All the genes necessary for GPL bio-
synthesis are clustered in a single region of the M. smegma-
tis genome, thus constituting a true "GPL locus" (Figure
3). In this species, most of the genes of the locus (Fig. 1)
have been identified experimentally and/or by in silico
prediction (Table 1). The tripeptide-aminoalcohol moiety
is non-ribosomally assembled by the product of the mps1
and the mps2 genes [18,19], and the lipid synthesis and
attachment to the tripeptide-aminoalcohol moiety proba-
bly require the concerted action of several gene products
(pks, fadD23, papA3) [19,20]. The genes involved in the
glycosylation of the lipopeptide core (gtf1,  gtf2) were
recently characterized by selectively inactivating them
both and by biochemical analysis of the resulting mutants
[21]. Triglycosylated GPLs, described as being produced
mostly during stationary phase [22], result from the addi-BMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
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tion of an extra rhamnosyl residue (gtf3) [9,21]. The genes
involved in the O-methylation of the various hydroxyl
groups of the rhamnosyl unit (rmt2, rmt3 and rmt4) and
of the lipid moiety (fmt) of the GPLs have been character-
ized using similar methods [23-25]. The atf gene product
is responsible for acetylating two particular hydroxyl resi-
dues of the dTal [26], and FadE5 probably introduces the
double bond into the fatty acid. The rmlA and rmlB genes
are associated with the activation and epimerisation of the
sugars [27]. Two members of the mmpL family, a group of
genes encoding large membrane proteins, are also
required for GPL biosynthesis [19,26]. The exact function
of these proteins, MmpL4a and MmpL4b, is not known in
detail although a recent study performed in M. tuberculosis
suggests that MmpL proteins (MmpL7) may channel the
polyketide products during their synthesis by the
polyketide synthase, coupling synthesis and export [28].
Finally, the transport of the GPLs to the surface of the
bacilli involves the integral membrane protein Gap [19].
This locus also contains eight other genes that have not yet
been experimentally characterized: two encode mem-
brane proteins (mmpS4 and mmpL10) that may also inter-
act with the polyketide synthase of the cluster, two encode
a sigma factor and a sigma-associated protein (ecf and sap,
respectively) that are believed to contribute to the regula-
tion of GPL production, and four have no known function
(Table 1 and Fig. 1) [18,19].
All the genes of the M. smegmatis GPL locus have close
orthologs in both M. chelonae and M. abscessus (Table 1).
These orthologs share more than 80% of identity with
each other and most are more than 90% identical (data
not shown). The percentage of identity between M. chelo-
nae/M. abscessus and  M. smegmatis orthologs ranges
between 30 and 89%, with two-thirds of M. chelonae/M.
abscessus orthologs being ≥70% identical to their M. smeg-
matis counterparts. Identity is less than 50% for only four
orthologs: sap, ecf, Rv0926 and Rv1174c. The functions of
Rv0926 and Rv1174c are not known, sap and ecf may play
roles in the regulation of GPL biosynthesis, and were this
the case, it would suggest that the regulatory circuits in
these species have diverged.
Unlike  M. smegmatis, the M. chelonae/M. abscessus GPL
orthologs are not gathered in a single region (Figure 3). In
both M. chelonae and M. abscessus, there is a large region
containing 19 genes (mmpS4 to gap). This region contains
all genes involved in the synthesis of the tripeptide-ami-
noalcohol moiety, the glycosylation of the lipopeptide
and the O-methylation and O-acetylation modifications
(see also Fig. 1). This region is very similar to the corre-
sponding region of the M. smegmatis GPL locus, except for
the two following differences. First, there is no mobile ele-
ment, either upstream of mbtH  like in M. smegmatis
mc2155 or at any other location. Second, there are two atf
orthologs (we called them atf1 and atf2) in both M. chelo-
nae and M. abscessus: atf1 is at the same location as atf in
M. smegmatis whereas atf2 is inserted between rmlB and
rmt2. M. chelonae atf1 and atf 2 genes are 58% identical
(71% similarity), and are 76 and 60% identical to M.
smegmatis atf respectively (88 and 75% similarity respec-
tively); M. abscessus atf1 and atf 2 genes are 57% identical
(72% similarity), and are 72 and 59% identical to atf
respectively (83 and 74% similarity respectively). There is
a smaller region forming a block of 6 genes 900 kb from
this first region in M. chelonae and 3 Mb away in M. absces-
sus. These six genes (pks to gap-like) are probably involved
in the lipid synthesis and attachment to the tripeptide-
aminoalcohol moiety (e.g., pks, fadD23, papA3), but pks is
the only one that has been experimentally studied so far
[19]. This block is part of a large region that is inverted
between M. chelonae and M. abscessus. It is very similar to
the corresponding part of the M. smegmatis GPL locus
except that the order of the pe and the fadD23 genes is
switched in M. chelonae/M. abscessus relative to M. smegma-
tis. Finally, four genes closely linked in M. smegmatis
(Rv0926, fadE5, sap, ecf) are scattered on the chromosome
in M. chelonae and M. abscessus, with distances differing
between species.
To test whether the locus organization was a particularity
of the sequenced strains (CIP 104535T and CIP
104536T), 5 clinical isolates of each species were analyzed
by PCR using two couples of primers (Additional file 1).
All the M. abscessus and M. chelonae isolates had the same
PCR pattern. This experiment shows that the genetic
organization of the GPL locus depicted in Figure 3 is not
strain-dependant but is probably valid for the whole spe-
cies.
Schematic representation of the structure of the GPLs from  M. smegmatis Figure 1
Schematic representation of the structure of the GPLs from 
M. smegmatis. The genes involved in the various metabolic 
steps are indicated in brackets. The locations of the variable 
substitutions linked to the common GPL core are shown. 
OAc: acetyl, OMe, methyl. dTal, 6-deoxytalose, D-Rha, 
rhamnose of the D series.BMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
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Acetyltransferases have evolved specificity in M. abscessus 
and M. chelonae
As seen above, there is only one atf in M. smegmatis while
there are two in both M. abscessus and M. chelonae. In M.
smegmatis, Atf catalyses the transfer of two acetyl groups
onto the dTal moiety (on positions 3 and 4) [26]. We con-
sequently tested whether the presence of the 2 atf in the
other species was a redundant or specialization process
and used atf1 and atf2 of M. abscessus as a model. We used
a M. smegmatis atf- mutant as a recipient host and comple-
mented it with constructs expressing the various atf genes
(Additional file 2). The GPLs produced by the various
complemented strains were analysed by both TLC and
MALDI-TOF. The GPLs produced by the M. smegmatis atf-
mutant were, as expected, non O-acetylated ([M+K+] m/z
at 1189 and 1215 amu) as deduced from the value of the
masses of the pseudomolecular ions and its altered migra-
tion on TLC. Reintroduction of the atf gene of M. smegma-
tis led to the production of O-diacetylated GPL ([M+K+]
m/z at 1273 and 1299 amu) with a wild type migration
pattern. Complementation by the atf1 gene of M. abscessus
was enabling the production of mono-O-acetylated GPL
([M+K+] m/z at 1231 and 1258 amu) having an interme-
diary migration between the di-O-acetylated and the non-
acetylated forms, indicating a specialisation process. Sur-
prisingly, the GPL produced by the M. smegmatis atf-
mutant complementated by the atf2 gene of M. abscessus
was most exclusively non-acetylated as judged by TLC
(Additional file 2) and MALDI-TOF analysis confirmed
molecular masses of 1189 and 1215 amu (data not
shown). However, when both atf1 and atf2 were simulta-
neously introduced into the host strain, the production of
di-O-acetylated GPLs was restored as judged by TLC
(Additional file 2) and MALDI-TOF analysis confirmed
molecular masses of 1273 and 1299 amu (data not
shown). This set of experiments shows that the atf2 gene
of M. abscessus is fully functional and needs a mono-O-
acetylated dTal substrate to be able to transfer the second
acetyl moiety. In conclusion, the acetyltransferases
encoded by the M. abscessus GPL locus are not redundant
A) Thin-layer chromatography analysis of the crude lipid extract of M. smegmatis (Ms), M. abscessus (Ma), and M. chelonae (Mc) Figure 2
A) Thin-layer chromatography analysis of the crude lipid extract of M. smegmatis (Ms), M. abscessus (Ma), and M. chelonae (Mc). 
Open rectangle, diglycosylated GPLs; closed rectangle, triglycosylated GPLs. B) MALDI-TOF mass spectra of the crude lipid 
fractions of M. smegmatis (Ms), M. abscessus (Ma), and M. chelonae (Mc). Open rectangle, diglycosylated GPLs; closed rectangle, 
triglycosylated GPLs.BMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
Page 5 of 9
(page number not for citation purposes)
but have evolved specificity, being able to transfer one
acetyl at once in a sequential manner.
Discussion
This study is the first addressing the genetics of GPL bio-
synthesis in two clinically significant RGM species, M. che-
lonae  and  M. abscessus. The major observation is that,
despite producing structurally identical GPL molecules,
the genes necessary for its biosynthesis are organized very
differently. In M. smegmatis, the GPL locus is made up of
almost 30 genes in a region of ~65 kb, and therefore does
not comply with the prokaryotic rule of 1 gene/kb. This is
because GPL biosynthesis involves very large multi-mod-
ular proteins, for example the non-ribosomal protein syn-
thetases (Mps1 and Mps2) and the polyketide synthase
(Pks), and consequently very long genes. Several genes
appear to be organized into operons, one of which has
been identified formally and contains mbtH, mps1, mps2,
gap,  sap  and  ecf  [19]. Interestingly, a mobile element,
IS1096, is located just upstream from mbtH in mc2155
strain. This upstream region corresponds to the promoter
of the mbtH operon and may therefore interfere with the
expression of this operon, as it does in other biological
systems [29,30]. Surprisingly, M. chelonae and M. abscessus
produced clearly more triglycosylated GPL than M. smeg-
matis. This observation argues in favour of differences in
gtf3 expression in these three species.
All the genes are clustered in M. smegmatis, but are scat-
tered in several blocks in M. chelonae and M. abscessus. The
various genomic pieces correspond to blocks of function:
one block corresponds to the synthesis of the tripeptide-
aminoalcohol moiety, the glycosylation of the lipopep-
tide and O-methylation/acetylation modifications, and
another to lipid biosynthesis and its attachment to the
tripeptide-aminoalcohol moiety. In addition, these spe-
cies differ by one inversion and one duplication. An
attractive hypothesis is that the compact organization of
the GPL locus in M. smegmatis represents the ancestral
form and that evolution has scattered various pieces
throughout the genome in M. abscessus and M. chelonae.
However, the opposite hypothesis in which genes
involved in a metabolic pathway would have the tendency
to gather during evolution cannot be excluded. The fact
that both M. chelonae and  M. abscessus have two non-
redundant  O-acetyltransferases suggests that atf2  may
Table 1: Genes of the M. smegmatis GPL locus and their orthologs in M. abscessus and M. chelonae.
M. smegmatis M. abscessus M. chelonae
Gene Gene n° Proposed function(a) Gene n° %(b) Gene n° %(b)
mmpS4 MSMEG0373 Membrane associated. Interaction with Pks, ° ma4117c 78 mc1618 74
mmpL4a MSMEG0374 Membrane associated. Interaction with Pks, ° ma 4116c 78 mc1619 77
mmpL4b MSMEG0375 Membrane associated. Interaction with Pks, ° ma4115c 76 mc1620 75
Rv1174 MSMEG0376 None ma4114 48 mc1621c 48
rmlA MSMEG0377 Alpha-D-hexose-1-phosphate-thymidylyl-transferase (EC 2.7.7.24), ° ma4113 85 mc1622c 85
gtf3 MSMEG0378 D-Rhamnose rhamnosyltransferase, + ma4112c 49 mc1623 71
rmlB MSMEG0379 UDP-hexose 4-epimerase, ° ma4111c 77 mc1624 78
rmt2 MSMEG0380 Rhamnose 2-O-methyltransferase, + ma4109c 72 mc1626 70
rmt4 MSMEG0381 Rhamnose 4-O-methyltransferase, + ma4108c 83 mc1627 83
gtf1 MSMEG0382 D-allo-threonine 6-deoxytalosyltransferase, + ma4107c 76 mc1628 77
atf MSMEG0383 Integral membrane protein. 6-deoxytalose 3,4-O-acetyltransferase, + ma4106c(c) 72 mc1629(c) 76
ma4110c(d) 59 mc1625(d) 60
rmt3 MSMEG0384 Rhamnose 3-O-methyltransferase, + ma4105c 81 mc1630 82
gtf MSMEG0385 L-alaninol rhamnosyltransferase, + ma4104 67 mc1631c 72
fmt MSMEG0386 Fatty acid O-methyltransferase, + ma4103c 67 mc1632 62
mbtH MSMEG0387 None ma4100c 89 mc1635 89
mps1 MSMEG0390 Non-ribosomal protein synthase. Synthesis of the dipeptide, +° ma4099c 70 mc1636 70
mps2 MSMEG0392 Non-ribosomal protein synthase. Synthesis of the amino acid alcohol, +° ma4098c 71 mc1637 72
gap MSMEG0393 Integral membrane protein. Required for GPL export, + ma4097c 58 mc1638 55
sap MSMEG0394 Sigma-associated protein ma4454c 30 mc1299 30
ecf MSMEG0395 Sigma factor of the ECF family. Required for regulation ma4459c 46 mc1294 47
fadE5 MSMEG0396 Fatty acid desaturase, ° ma4437 78 mc1318c 78
Rv0926 MSMEG0397 None ma4633 36 mc1136c 36
pks MSMEG0398 Fatty acid synthesis and activation, +° ma0939 79 mc0819 79
papA3 MSMEG0399 Transfer of the Pks-bound fatty acid to the pseudotetrapeptide, ° ma0938c 77 mc0818c 77
mmpL10 MSMEG0400 Membrane associated. Interaction with Pks, ° ma0937c 75 mc0817c 74
fadD23 MSMEG0401 Long chain fatty acyl-AMP ligase, ° ma0935c 73 mc0815c 74
pe MSMEG0402 None ma0936c 64 mc0816c 66
gap-like MSMEG0403 Integral membrane protein. Role in the transport of GPLs, ° ma0934 55 mc0814 55
(a) +, experimentally validated function; °, in silico predicted function.
(b) Percentage of identity between M. abscessus or M. chelonae genes and M. smegmatis genes.
(c) atf1 (see text and legend to Fig. 3).
(d) atf2 (see text and legend to Fig. 3).BMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
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have arisen from the duplication of atf1. Interestingly, atf1
is less similar to atf2 than to M. smegmatis atf, also indicat-
ing a functional divergence between atf1 and atf2. In M.
smegmatis, atf mediates the O-acetylation of the dTal in
both positions 3 and 4. We showed that, in M. abscessus,
atf1 and atf2 are each specifically responsible for one of
these two reactions and that probably act sequentially.
We showed that the GPL biosynthetic pathway is highly
conserved between M. chelonae and M. abscessus, consist-
ent with the close relatedness of these two species [31].
However, due to genomic rearrangements between the
two species, the two blocks are located at different coordi-
nates and the block of six genes is inverted in these two
species with respect to that in M. smegmatis. These
genomic rearrangements are consistent with the separa-
tion of the two species that were formerly parts of a single
complex [31]. We showed, using a panel of clinical iso-
lates that these differences are species-specific, and may
thus be used as a discriminative marker. The genomic
findings are in agreement with the biochemical data
showing that the two species produce structurally identi-
cal GPL molecules [3]. However, differences in terms of
regulation cannot be excluded and it is not known
whether additional genes are needed for GPL biosynthe-
sis, export and regulation in these three species.
M. chelonae and M. abscessus, like other mycobacterial spe-
cies [32,33], can naturally switch from a rough (R) to
smooth (S) and from a S to a R morphotype [12,13]. R
strains are associated with a low GPL production, high
invasive ability and a higher virulence in the mouse
model [13,14]. However, despite several attempts, the
genetic bases for this natural S/R switching remain
obscure. Several studies using M. avium and M. smegmatis
describe various genes involved in the transition between
S and R morphotypes, most of which are implicated in the
GPL biosynthetic pathway [18,19,34]. The identification
of the genes required for the synthesis and export of these
metabolites should help our understanding of the natural
variation in the morphology and virulence variation of
these species.
Conclusion
We showed that M. abscessus and  M. chelonae contain
genes corresponding to all those of the M. smegmatis "GPL
locus" with an extensive conservation of the predicted
protein sequences. This finding is consistent with the pro-
Genetic organization of the GPL locus in M. smegmatis (Ms), M. abscessus (Ma), and M. chelonae (Mc) Figure 3
Genetic organization of the GPL locus in M. smegmatis (Ms), M. abscessus (Ma), and M. chelonae (Mc). The ORFs are depicted as 
arrows and have been drawn to scale. Colour code: Light blue: mmpL family, black: unknown, purple: sugar biosynthesis, activa-
tion, transfer and modifications, red: lipid biosynthesis, activation, transfer and modifications, green: pseudopeptide biosynthe-
sis, yellow: required for GPL transport to the surface, grey: regulation.BMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
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duction of GPL molecules indistinguishable by either
thin-layer chromatography or mass spectrometry.
Despite, the genomic and structural homology, the GPL
locus appears to be split into several parts in M. chelonae
and M. abscessus. One large cluster (19 genes) comprises
all genes involved in the synthesis of the tripeptide-ami-
noalcohol moiety, the glycosylation of the lipopeptide
and O-methylation/acetylation modifications. A second
smaller and distant (M. chelonae, 900 kb; M. abscessus, 3
Mb) cluster of six genes is involved in the synthesis of the
fatty acyl moiety and its attachment to the tripeptide-ami-
noalcohol moiety. The other genes are scattered through-
out the genome, including two genes encoding putative
regulatory proteins. Although these three species produce
identical GPL molecules, the organization of GPL genes
differs between them, thus constituting species-specific
signatures. An attractive hypothesis is that the compact
organization of the GPL locus in M. smegmatis represents
the ancestral form and that evolution has scattered vari-
ous pieces throughout the genome in M. abscessus and M.




M. smegmatis mc2155 and M. abscessus CIP104536T
(ATCC 19977T) were cultured in 7H9 supplemented with
10% ADC at 37°C. M. chelonae CIP 104535T (ATCC
35752T) was cultured in the same medium at 30°C. All
bacterial cultures were harvested in either early exponen-
tial or late stationary phase. When required, antibiotics
were included at the following concentrations: kanamy-
cin, 50 μg/ml, hygromycin, 200 μg/ml (for E. coli) or 50
μg/ml (for mycobacteria).
Lipid analysis
Lipids were extracted from cells with a mixture of chloro-
form and methanol and further partitioned by methanol
precipitation as previously described [11]. The GPLs (250
μg lipid each deposit) were identified by TLC on silica gel
Durasil 25-precoated plates (Macherey-Nagel) run in
chloroform/methanol (90:10 [vol/vol]) and using
MALDI-TOF mass spectrometry analysis [11]. These sugar-
containing compounds were identified by spraying plates
with 0.2% anthrone in concentrated sulfuric acid, fol-
lowed by heating at 110°C [7].
Computer methods
The accession number of the GPL locus of M. smegmatis is
AY439015. The sequencing and the assembly of the
genome of M. abscessus and M. chelonae was performed by
the CNS (Centre National de Séquençage-Evry-France),
[35]. Open reading frames of both M. abscessus and M.
chelonae  were predicted using both SHOW [36] and
ARTEMIS [37]. The accession numbers corresponding to
the regions of the GPL locus of M. abscessus are AM31616
to AM31621. The accession numbers corresponding to
the regions of the GPL locus of M. chelonae are AM231610
to AM231615. The complete sequence of M. abscessus and
M. chelonae will be reported elsewhere (J. L Risler & J. L
Gaillard, unpublished data). The 6901 putative proteins
of the genome of M. smegmatis were obtained from The
Institute for Genomic Research [38]. The comparative
genomic analysis was performed by pairwise alignments
between the proteins of the GPL locus of M. smegmatis and
each of the complete proteomes mentioned above. These
comparisons were performed using the LASSAP software
and Z-values were calculated as described [16,17]. The
identification of the orthologous links was performed
using the results of the pairwise comparisons as follows:
For each gene of the GPL locus of M. smegmatis, 5 bi-direc-
tional best hits (BBH) were identified. The BBH having
the best Z-value was selected. When several BBH exhibited
a similar Z-value (some of the genes of the GPL locus such
a fadD and fadE are affected by a high degree of paralogy),
the gene preserving the syntenic context was selected.
Identity below 25% was not considered as significant. All
the selected orthologs have a Z-value greater than 14
(except the sap gene and its orthologs).
Analysis of the M. abscessus and M. chelonae clinical 
isolates using PCR
The chromosomal DNA was prepared using the bead-
beater-phenol extraction method. The bacterial pellet
(corresponding to 50 ml culture) were suspended in 5 ml
of solution I (25% sucrose; 50 mM TrisCl 1 M pH = 8; 50
mM thiourea; 10 mg/ml lysozyme). The thiourea inhibits
the Tris-dependent DNAse that is present in some strains
[39]. Solution II (25% sucrose; 50 mM TrisCl pH = 8; 50
mM EDTA pH = 8) was added and the bacterial cells were
lysed as described by Howard and al. [40]. Proteinase K
was added to the lysate at 100 μg/ml and incubated over-
night at 55°C. The DNA was extracted using phenol/chlo-
rophorm/isoamyl-alcohol (25:24:1) and precipitated
with propanol. Primers (mpsF1, mpsF2, mpsR; pkF1,
pkF2, pkR) (Additional file 3) were designed according to
the chromosomal sequence of M. abscessus and M. chelo-
nae. PCR amplification was performed using Dynazyme
Taq polymerase according to manufacturer instructions
(Finnzyme, Espoo, Finland).
Construction of acetyltransferase expression plasmids
The wild type M. smegmatis atf gene (accession number
AY138899) coding sequence was amplified by PCR using
the Pfu DNA Polymerase (Stratagene), the genomic DNA
of M. smegmatis mc2155 as template and primers contain-
ing an engineered XbaI site (atfsmeg.5 and atfsmeg.3)
(Additional file 3). After purification with the PCR purifi-
cation Qiagen kit, PCR products were digested with XbaI
and cloned into the dephosphorylated expression vectorBMC Genomics 2007, 8:114 http://www.biomedcentral.com/1471-2164/8/114
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pNIP40b [41] at the unique XbaI site to generate pNIPat-
fsmeg. One clone having the atfsmeg gene inserted in the
opposite direction of the hygromycin resistant gene was
selected and sequenced. Using M. abscessus ATCC 19977T
genomic DNA as template, a similar strategy was applied
to clone atf1 gene and atf2 gene (AM231618) using prim-
ers atf1abs.5/atf1abs.3 and primers atf2abs.5/atf2abs.3
(Additional file 3) into pNIP40b [41] yielding
pNIPatf1absc and pNIPatf2absc, respectively. To clone the
M. abscessus atf1 and atf2 genes in frame, the af1absc PCR
product was digested by ClaI and the atf2 gene was ampli-
fied using new primers (atf2ClaI.5 and atf2abs.3) and
digested with ClaI. The 2 PCR products were digested with
XbaI, purified and ligated, with the dephosphorylated
expression vector pNIP40b at its unique XbaI site to gen-
erate pNIPatf1_2absc. These plasmids were electroporated
into M. smegmatis mc2155 atf- mutant [26] and transform-
ants were selected on plates containing kanamycin and
hygromycin. These strains are named atf-/atfsMs,  atf-/
atf1Ma, atf-/atf2Ma and atf-/atf1_2Ma.
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